A new label design from PharMEDium should make a medication's name and dose easier to read and recognize. The enhanced labeling will be applied first to four patient-controlled, IV pain-management drugs as well as local anesthetics for nerve-block therapy.

Three companies are offering resources to help pharmacists with compounding.

The U.S. Senate, following in the footsteps of the House, has introduced a resolution urging FDA to lift its restrictions on the use of estriol in bioidentical hormone preparation.

To better ward off blows by the FDA to compounding pharmacists, IACP has established a satellite office at NCPA's headquarters.

The Centers for Medicare & Medicaid Services has issued an FAQ that explains about the use of a non-NPI for prescribers who are not covered entities.

Since three steroids have a high potential for drug abuse and trafficking, the Drug Enforcement Administration wants to classify them as Schedule III controlled substances.

An expert contends that pharmacists should learn about pharmacogenetics and get into the field now

The infusion provider InfuScience has added two pharmacies in Florida

Insmed has received a questionnaire from House of Representatives' Subcommittee on Health on develdoping legislation to establish a follow-on biologics regulatory pathway.